📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Hypoxia-activated KDAC inhibitor: Taking a breath from untargeted therapy (2021)

First Author: Staudt M

Attributed to: Chemical bioreductive approaches to targeted radiosensitisation and imaging of tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.chembiol.2021.08.016

Publication URI: http://dx.doi.org/10.1016/j.chembiol.2021.08.016

Type: Journal Article/Review

Parent Publication: Cell Chemical Biology

Issue: 9